AR040830A1 - Vacuna para combatir la infeccion que produce la mastitis - Google Patents

Vacuna para combatir la infeccion que produce la mastitis

Info

Publication number
AR040830A1
AR040830A1 AR20030102870A ARP030102870A AR040830A1 AR 040830 A1 AR040830 A1 AR 040830A1 AR 20030102870 A AR20030102870 A AR 20030102870A AR P030102870 A ARP030102870 A AR P030102870A AR 040830 A1 AR040830 A1 AR 040830A1
Authority
AR
Argentina
Prior art keywords
nucleic acid
proteins
parts
acid sequences
immunogenic
Prior art date
Application number
AR20030102870A
Other languages
English (en)
Inventor
Selma Marianne Hensen
Petrus Johannes Nuijten
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AR040830A1 publication Critical patent/AR040830A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Secuencias de ácidos nucleicos que codifican a una proteína de Streptococcus uberis de 22,5 KD y a partes de tales secuencias de ácidos nucleicos que codifican a un fragmento inmunogénico de tales proteínas y a fragmentos de DNA, moléculas de DNA recombinante, vehículos recombinantes vivos y células huésped que comprenden a tales secuencias de ácidos nucleicos o tales partes de las mismas. Una proteína de Streptococcus uberis de 22,5 KD y a partes inmunogénicas de la misma codificadas por tales secuencias. Vacunas que comprenden a tales secuencias de ácidos nucleicos y partes de la mismas, fragmentos de DNA, moléculas de DNA recombinante, vehículos recombinantes vivos y células huésped que comprenden a tales secuencias de ácidos nucleicos o partes de las mismas, a proteínas o partes inmunogénicas de las mismas y a anticuerpos contra tales proteínas o partes inmunogénicas de las mismas. Uso de dichas proteínas en vacunas y para la elaboración de vacunas. Uso de dichas secuencias de ácido s nucleicos, proteínas o anticuerpos para propósitos de diagnóstico o de vacunación. Kits de diagnóstico que comprenden a tales ácidos nucleicos, proteínas o anticuerpos contra tales proteínas. Reivindicación 1: Secuencia de ácidos nucleicos que codifica a la proteína de Streptococcus uberis de 22,5 KD o una parte de dicha secuencia de ácidos nucleicos que codifica a un fragmento inmunogénico de dicha proteína, teniendo dicha secuencia de ácidos nucleicos o dicha parte de la misma una homología de por lo menos 85% con la secuencia de ácidos nucleicos del gen de la proteína de Streptococcus uberis como se ilustra en la SEQ ID NO: 1.
AR20030102870A 2002-08-12 2003-08-08 Vacuna para combatir la infeccion que produce la mastitis AR040830A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02078325 2002-08-12

Publications (1)

Publication Number Publication Date
AR040830A1 true AR040830A1 (es) 2005-04-20

Family

ID=31896912

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20030102870A AR040830A1 (es) 2002-08-12 2003-08-08 Vacuna para combatir la infeccion que produce la mastitis

Country Status (9)

Country Link
US (1) US7601804B2 (es)
EP (1) EP1532253B1 (es)
JP (1) JP2005535350A (es)
AR (1) AR040830A1 (es)
AU (1) AU2003251694B2 (es)
BR (1) BR0313237A (es)
CA (1) CA2494197C (es)
NZ (1) NZ538075A (es)
WO (1) WO2004018683A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112409495A (zh) * 2020-10-28 2021-02-26 天津农学院 一种猪链球菌重组zsd重组亚单位疫苗、重组表位原核质粒、制备和应用
PL442091A1 (pl) 2022-08-25 2024-02-26 Uniwersytet Jagielloński Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
ES2056565T3 (es) 1990-07-30 1994-10-01 Akzo Nobel Nv Virus recombinante de la enfermedad de marek.
FR2714074B1 (fr) 1993-12-20 1996-03-01 Pasteur Institut Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs.
DK1332155T3 (da) * 2000-06-12 2007-02-26 Univ Saskatchewan Vaccination af malkekvæg med GapC protein mod streptokokinfektion
US6866855B2 (en) * 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
PT1294771E (pt) * 2000-06-12 2009-01-06 Univ Saskatchewan Proteína gapc quimérica de streptococcus e sua utilização em vacinação e diagnóstico
NZ560966A (en) * 2000-10-27 2010-06-25 Novartis Vaccines & Diagnostic Nucleic acids and proteins from streptococcus groups A & B
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
US7005885B1 (en) 2003-02-21 2006-02-28 Aeluros, Inc. Methods and apparatus for injecting an external clock into a circuit
US8043109B2 (en) 2009-07-27 2011-10-25 Avx Corporation Wire to board connector

Also Published As

Publication number Publication date
JP2005535350A (ja) 2005-11-24
CA2494197C (en) 2012-10-09
EP1532253B1 (en) 2014-04-30
US7601804B2 (en) 2009-10-13
EP1532253A1 (en) 2005-05-25
US20050255125A1 (en) 2005-11-17
AU2003251694B2 (en) 2009-09-17
CA2494197A1 (en) 2004-03-04
NZ538075A (en) 2006-05-26
BR0313237A (pt) 2005-07-12
WO2004018683A1 (en) 2004-03-04
AU2003251694A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
BR0015137A (pt) Peptìdeos antigênicos de neisseria
DE69739515D1 (de) Expressionsvektoren, die eine antigen-spezifische immunantwort induzieren, und methoden für ihre verwendung.
BRPI0707154B8 (pt) composição de vacina
CA2408328A1 (en) Immunogenic polypeptides encoded by mage minigenes and uses thereof
BR112022016550A2 (pt) Proteínas de ligação a flt3 e métodos de uso
BRPI0507017A (pt) ácido nucleico que codifica uma proteìna de lawsonia intracellularis, fragmento de dna, molécula de dna recombinante, carreador recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, uso da mesma, vacina para combater as infecções por lawsonia intracellularis, método para preparação da mesma, e, teste de diagnóstico
NZ735684A (en) Materials and methods for respiratory disease control in canines
RU2009123028A (ru) F-белок респираторно-синцитиального вируса (rsv) и его применение
AR053372A1 (es) Proteinas inmunologicas de lawsonia intracellularis
HUP0105379A2 (hu) Lawsonia intracellularis elleni oltóanyag
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
AR040830A1 (es) Vacuna para combatir la infeccion que produce la mastitis
AR036793A1 (es) Vacunas de acido nucleico que utilizan acidos nucleicos que codifican un antigeno de tumor con un acido nucleico que codifica una citoquina como adyuvante
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
ZA200602107B (en) Piroplasmid vaccine
AR041243A1 (es) Vacuna para ostertagia
NO20081541L (no) Ny sjo-lus vaksine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
HUP0102306A1 (hu) A csonka kolinkötő protein A N-terminális aminosavait tartalmazó polipeptid, ebből származó vakcina és ezek alkalmazása
BRPI0412419A (pt) proteìna de babésia, ácido nucleico, fragmento de cdna, molécula de dna recombinante, veìculo recombinante vivo, célula hospedeira, vacina, método para a preparação de uma vacina, uso de uma proteìna ou um fragmento imunogênico de referida proteìna, e, testes diagnósticos para a detecção de um ácido nucleico associado com, para a detecção de anticorpos contra, e para a detecção de material antigênico de um organismo da famìlia babesiidae
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
DE50106199D1 (de) Regulatorische sequenz zur spezifischen expression in dendritischen zellen und deren anwendungen
BRPI0417440A (pt) ácido nucleico, fragmento e molécula de dna, veìculo recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, vacina para combater as infecções com lawsonia intracelularis, método para a preparação de uma vacina, e, testes de diagnóstico para aldetecção de anticorpos contra lawsonia intracellularis e material antigênico de lawsonia intracellularis
ZA200607741B (en) Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays
HUP0200832A2 (hu) Babesia canis oltóanyag

Legal Events

Date Code Title Description
FB Suspension of granting procedure